WallStreetZenWallStreetZen

NASDAQ: CRNX
Crinetics Pharmaceuticals Inc Stock Ownership - Who owns Crinetics Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crinetics Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard Scott StruthersPresident CEO2025-04-0281,270$1.91
$155.23kBuy
Richard Scott StruthersPresident CEO2025-03-19875$34.83
$30.48kSell
Stephen F. BetzChief Scientific Officer2025-03-195,479$34.17
$187.22kSell
Stephen F. BetzChief Scientific Officer2025-03-19291$34.83
$10.14kSell
Jeff E. KnightChief Operating Officer2025-03-196,801$34.17
$232.39kSell
Dana PizzutiChief Med and Dev Officer2025-03-192,388$34.17
$81.60kSell
Dana PizzutiChief Med and Dev Officer2025-03-19127$34.83
$4.42kSell
Richard Scott StruthersPresident CEO2025-03-1916,463$34.17
$562.54kSell
Jeff E. KnightChief Operating Officer2025-03-19361$34.83
$12.57kSell
Dana PizzutiChief Med and Dev Officer2025-02-035,000$16.89
$84.45kBuy

1 of 5

CRNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRNX insiders and whales buy or sell their stock.

CRNX Shareholders

What type of owners hold Crinetics Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.98%14,031,269$445.77MInstitution
Vanguard Group Inc9.94%9,311,600$295.83MInstitution
Perceptive Advisors LLC8.44%7,908,985$251.27MInsider
Blackrock Inc8.17%7,656,569$243.25MInstitution
Wellington Management Group LLP7.36%6,891,397$218.94MInstitution
Driehaus Capital Management LLC6.66%6,239,902$198.24MInstitution
Price T Rowe Associates Inc5.46%5,112,360$162.42MInstitution
Farallon Capital Management LLC4.92%4,605,098$146.30MInstitution
Ecor1 Capital LLC4.58%4,288,120$136.23MInstitution
Janus Henderson Group PLC3.66%3,424,442$108.79MInstitution

1 of 3

CRNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRNX88.82%11.18%Net BuyingNet Buying
VKTX67.83%8.96%Net SellingNet Buying
KYMR79.14%20.86%Net SellingNet Buying
SRRK59.81%40.19%Net SellingNet Selling
CPRX79.95%15.82%Net SellingNet Selling
View Top Biotech Stocks

Crinetics Pharmaceuticals Stock Ownership FAQ

Who owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals (NASDAQ: CRNX) is owned by 108.76% institutional shareholders, 13.69% Crinetics Pharmaceuticals insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Crinetics Pharmaceuticals shareholder, owning 7.91M shares representing 8.44% of the company. Perceptive Advisors LLC's Crinetics Pharmaceuticals shares are currently valued at $251.27M.

If you're new to stock investing, here's how to buy Crinetics Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.